Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Disparities in Stage at Diagnosis among Hispanic Patients with Gastric Cancer in the United States.
Journal: Cancers
Published: July 25, 2024
Survival Analysis of Metastatic Early-Onset Colorectal Cancer Compared to Metastatic Average-Onset Colorectal Cancer: A SEER Database Analysis.
Journal: Cancers
Published: May 02, 2024
Multiplexed immunohistochemical analysis of the immune microenvironment of biliary tract cancers pre- & post-neoadjuvant chemotherapy: case series.
Journal: Annals of translational medicine
Published: November 18, 2023
Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma.
Journal: World journal of gastrointestinal oncology
Published: May 21, 2023
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: August 12, 2022
The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma.
Journal: Cancers
Published: October 14, 2021
Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC.
Journal: Hepatology communications
Published: August 03, 2021
Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: Evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practice.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 22, 2021
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma.
Journal: Therapeutic advances in medical oncology
Published: December 20, 2020
Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy.
Journal: Journal for immunotherapy of cancer
Published: September 02, 2020
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study.
Journal: Journal for immunotherapy of cancer
Published: July 06, 2020
Last Updated: 09/26/2026